High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma.

MLA

Bi, Xi-wen, et al. “High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma.” PLoS ONE, vol. 11, no. 3, Mar. 2016, pp. 1–12. EBSCOhost, https://doi.org/10.1371/journal.pone.0152842.

APA

Bi, X., Wang, L., Zhang, W., Sun, P., Yan, S., Liu, P., Li, Z., & Jiang, W. (2016). High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma. PLoS ONE, 11(3), 1–12. https://doi.org/10.1371/journal.pone.0152842

Chicago

Bi, Xi-wen, Liang Wang, Wen-wen Zhang, Peng Sun, Shu-mei Yan, Pan-pan Liu, Zhi-ming Li, and Wen-qi Jiang. 2016. “High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma.” PLoS ONE 11 (3): 1–12. doi:10.1371/journal.pone.0152842.